About Marker Therapeutics
Investors/Media
SEC Filings
Filing date Form Description View
10-Q

Quarterly report which provides a continuing view of a company's financial position

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
DEFR14A

DEFR14A    

View HTML
DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

View HTML
DEFA14A

Additional proxy soliciting materials - definitive

View HTML
SC 13D/A

An amendment to a SC 13D filing

View HTML
SC 13D/A

An amendment to a SC 13D filing

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML

Data provided by Kaleidoscope.